Three Greenphire Volunteers Share Their Personal COVID-19 Vaccine Trial Experiences

In 2020, the COVID-19 pandemic forced the scientific community across the globe to mobilize at “warp speed” to evaluate potential treatments and vaccines to stem morbidity and mortality from the virus.  The rapid progress required tremendous resources, collaboration, and innovation across the pharmaceutical industry and government.

Essential to evaluating potential vaccines, thousands of healthy individuals raised their hands to volunteer for participation in vaccine trials.  Three Greenphire employees described in this article were among the hundreds of thousands of clinical trial volunteers participating in COVID Phase III vaccine clinical trials.

What inspired them to participate?  The desire to make a difference for the health of society globally.  Through their participation, meaningful insights were obtained regarding the actual experience of clinical trial participants, who we support at Greenphire with our technology solutions.  Below are some of these insights.